http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0337938-A3

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J7-00
filingDate 1989-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1990-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0337938-A3
titleOfInvention 19-norprogesterone derivatives in the treatment of osteoporosis
abstract The invention provides the use of a progestin unsubstituted in the 19 nposition in the manufacture of a medicament for the treatment of nestablished osteoporosis on a non-cyclical basis.
priorityDate 1988-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0235090-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID228864
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426988
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399016

Total number of triples: 19.